Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.78 USD | -1.09% | -2.35% | -8.50% |
05-31 | Piper Sandler Starts Arcellx With Overweight Rating, $70 Price Target | MT |
05-15 | Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARCELLX, INC. | Other Biotechnology & Medical Research | -1.09% | -2.35% | -8.50% | +20.96% | - | 2.72B |
- Stock Market
- Equities
- ACLX Stock
- Charts Arcellx, Inc.
- Relative Strength Chart